— Know what they know.
Not Investment Advice
Also trades as: GLPG.AS (AMS) · $vol 3M · LKFT.AS (AMS) · $vol 3M

GLPGF Earnings

Lakefront Biotherapeutics
1W: +0.0% 1M: +21.8% 3M: +13.8% YTD: +2.1% 1Y: -4.5% 3Y: -19.1% 5Y: -72.8%
$31.95
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 62 · $2.1B mcap · 45M float · 0.0000% daily turnover · Short 100% of daily vol
Last Earnings 2026-08-10
EPS
€0.03 (US$0.04)
▲ Beat +115.0%
Revenue
€14M ($16M)
▲ Beat +32.8%
EPS Beat Streak: 3 quarters
Next Earnings 2026-11-11
EPS Estimate
€-1.04 (US$-1.17)
Range: €-2.30 - €0.22
Revenue Estimate
€7M ($8M)
1 analysts
1 USD = 0.89 EUR

Estimate vs Actual

Earnings Surprise History

14/19
EPS Beats
13/19
Revenue Beats
74%
EPS Beat Rate
68%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 quarter 2028-12-30 €-0.49 €-0.49 — €7,011,423 €6,963,750
2026-10-02 quarter 2026-09-30 €-0.72 €-0.72 — €6,457,978 €6,465,318
2026-10-02 annual 2026-12-31 €-2.19 €-2.17 ▲ 0.02 €27,852,655 €27,663,274
2026-10-02 quarter 2026-12-30 €-1.05 €-1.04 ▲ 0.01 €6,834,720 €6,788,248
2026-10-02 quarter 2027-03-30 €-0.42 €-0.42 — €6,951,411 €6,904,146
2026-10-02 quarter 2027-09-30 €-0.44 €-0.44 — €6,951,411 €6,904,146
2026-10-02 quarter 2028-06-30 €-0.47 €-0.47 — €7,011,423 €6,963,750
2026-10-02 annual 2030-12-31 €-2.96 €-2.94 ▲ 0.02 €37,475,809 €37,220,997
2026-10-02 annual 2027-12-31 €-2.08 €-2.06 ▲ 0.02 €34,367,847 €34,134,167
2026-10-02 quarter 2028-09-30 €-0.48 €-0.48 — €7,011,423 €6,963,750
2026-10-02 quarter 2028-03-30 €-0.46 €-0.46 — €7,011,423 €6,963,750
2026-10-02 quarter 2027-06-30 €-0.43 €-0.43 — €6,951,411 €6,904,146
2026-10-02 annual 2028-12-31 €-2.60 €-2.58 ▲ 0.02 €28,269,707 €28,077,490
2026-10-02 quarter 2027-12-30 €-0.45 €-0.45 — €6,951,411 €6,904,146
2026-10-02 annual 2029-12-31 €-2.62 €-2.61 ▲ 0.01 €32,134,524 €31,916,030
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms